灰阶与线性标度肝肾指数定量评估脂肪肝的临床评价:中国原住民族群的前瞻性研究
前瞻性纳入106例不同分期非酒精性脂肪性肝病(NAFLD)患者,以超声脂肪肝指标(US-FLI)为参考标准,评估传统灰阶肝肾指数(GS-HRI)与新型线性标度肝肾指数(LS-HRI)的诊断效能。两种测量在两名超声医生间重复性均优(CCC分别为0.900和0.822),LS-HRI与US-FLI的线性相关性(R=0.74)明显优于GS-HRI(R=0.46)。
要点
- GS-HRI与LS-HRI在两名超声医生间重复性均优,CCC分别为0.900与0.822。
- LS-HRI与US-FLI的线性相关性(R=0.74)明显优于GS-HRI(R=0.46)。
- LS-HRI鉴别脂肪肝与正常肝的敏感度85.9%、特异度96.3%、AUROC 95.5%。
核心结论
- GS-HRI与LS-HRI测量在两名超声临床医生间均具有重复性,且对脂肪肝检测均明显有效。
研究设计与样本
- 前瞻性研究纳入106例不同分期NAFLD患者;超声图像由一名高年资超声医生采集并获取US-FLI评分,GS-HRI与LS-HRI由另外两名超声医生离线测量;以US-FLI评分为参考标准确定四个脂肪变分级。
诊断标准与关键数值
- LS-HRI鉴别脂肪肝与正常肝:敏感度85.9%、特异度96.3%、AUROC 95.5%。
- GS-HRI鉴别脂肪肝与正常肝:敏感度85.9%、特异度92.6%、AUROC 94.7%。
- GS-HRI观察者间一致性CCC为0.900,LS-HRI为0.822。
- LS-HRI与US-FLI线性相关R=0.74,GS-HRI与US-FLI线性相关R=0.46。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND AIMS: Hepato-renal index (HRI) has been investigated extensively in various clinical studies. New linear scale HRI (LS-HRI) is proposed as an alternative to conventional grayscale HRI (GS-HRI) that suffers from lack of a widely accepted cut-off value for differentiation of fatty from normal livers. To investigate the diagnostic performance of conventional GS-HRI and new LS-HRI for a relatively large Chinese population with NAFLD using a well-established ultrasonographic fatty liver indicator (US-FLI) as the reference standard for steatosis grades.
MATERIALS AND METHODS: A total of 106 patients with various stages of NAFLD were prospectively enrolled. All ultrasound images for these patients were first acquired by a highly experienced ultrasound doctor and their US-FLI scores then obtained by the same doctor. Both GS-HRI and LS-HRI values were measured off-line by two additional ultrasound doctors. Four steatosis grades were determined from US-FLI scores for steatosis detection and staging.
RESULTS: Inter-observer agreements for both GS-HRI and LS-HRI were excellent with the respective concordance correlation coefficient (CCC) of 0.900 for GS-HRI and 0.822 for LS-HRI. A linear correlation to US-FLI for LS-HRI (R = 0.74) was substantially superior to that for GS-HRI (R = 0.46). LS-HRI had a sensitivity of 85.9% and a specificity of 96.3% to differentiate steatosis from the normal liver (AUROC: 95.5%) while GS-HRI had a sensitivity of 85.9% and a specificity of 92.6% to distinguish steatosis from the normal liver (AUROC: 94.7%).
CONCLUSIONS: Both GS-HRI and LS-HRI measurements are reproducible between two ultrasonographic clinicians and are evidently effective for steatosis detection.
引用
- Zhou H, Zhou Y, Ding J, et al. Clinical evaluation of grayscale and linear scale hepatorenal indices for fatty liver quantification: a prospective study of a native Chinese population. Abdom Radiol (NY). 2022. PMID: 35150314. doi:10.1007/s00261-022-03434-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。